Women's Health
Boston Scientific prices $1.85B debt offering
Bayer: 5-year results confirm Essure’s safety and effectiveness
Hologic raises outlook again after Street-beating Q2
Guided Therapeutics eyes China with $775k share sale
Gynesonics raises $3m for VizAblate fibroid device
California’s Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.
New mammography guidelines stick with screening from age 50
Bioness launches clinical trial for StimRouter in overactive bladder
Bioness last week said it’s making progress with a Canadian study of its StimRouter neuromodulation device designed to expand the number of conditions for which it can be used for treatment.